Download Unicorn Signals App

Powered By EquityPandit

EquityPandit

EquityPandit
 Signals, Powered By  EquityPandit
Latest News

Lupin going to buy 21 branded drugs from Japan’s Shionogi

Lupin Ltd.'s plant stands in Goa, India, in this 2011 handout photograph released to the media on July 27, 2012. Lupin Ltd., the world's biggest maker of drugs to treat tuberculosis, plans to acquire brands in the U.S. to reduce its reliance on less profitable generic medicines, President Nilesh Gupta said. Source: Lupin Ltd. via Bloomberg EDITOR'S NOTE: NO SALES. EDITORIAL USE ONLY.

Lupin, the Indian drugmaker had agreed to buy a portfolio of 21 drugs from Japan’s Shionogi & Co for 15.4 billion yen (USD 150 million).

The companies said in a statement that the portfolio will be transferred to Lupin on December 31, subject to regulatory approvals and certain closing conditions.

The acquisition that is going to be done by Lupin’s Japanese generic drug unit Kyowa Pharmaceutical Industry Co Ltd, will be providing Lupin the access to Japanese branded pharmaceutical market and strengthen its speciality business portfolio.

Read EquityPandit’s Technical Analysis on Nifty Pharma 

Get Daily Prediction & Stocks Tips On Your Mobile


@2024 - www.equitypandit.com. All Right Reserved. Designed and Developed by PenciDesign